We entered FBXO7, RAD23A, and MKRN1 into the camp database and eventually identified 11 drugs that could be used to treat coronary artery disease, including doxorubicin, gabapentin, suxibuzone, prasterone, kawain, 5255229, decline, nalbuphine, MK-801, trimethoprim, and GW-8510 (Table 1). This evidence concerns the gene MKRN1 and coronary artery disorder.